BIODESIX INC (BDSX) Stock Balance Sheet
NASDAQ:BDSX - Nasdaq - US09075X1081 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 17.60M | 26.25M | 26.28M | 43.10M | 32.70M | |||
| Receivables | 7.64M | 8.60M | 7.68M | 5.10M | 3.70M | |||
| Other Current Assets | 4.38M | 4.64M | 5.72M | 5.20M | 7.20M | |||
| Total Current Assets | 29.62M | 39.48M | 39.68M | 53.30M | 43.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 28.93M | 29.59M | 29.61M | 8.80M | 4.20M | |||
| Goodwill | 15.03M | 15.03M | 15.03M | 15.00M | 15.00M | |||
| Intangibles | 5.36M | 5.87M | 7.91M | 9.80M | 11.60M | |||
| Other Non-Current Assets | 7.30M | 7.26M | 6.86M | 5.90M | 1.70M | |||
| Total Non-Current Assets | 56.62M | 57.76M | 59.41M | 39.60M | 32.50M | |||
| TOTAL ASSETS | 86.24M | 97.24M | 99.10M | 92.90M | 76.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 18.00K | 21.00K | 51.00K | 0.00 | 0.00 | |||
| Accrued Expenses | 6.31M | 8.41M | 5.09M | 7.40M | 4.90M | |||
| Accounts Payable | 2.92M | 2.19M | 2.93M | 1.70M | 1.70M | |||
| Other Current Liabilities | 4.07M | 3.69M | 25.35M | 13.70M | 22.40M | |||
| Total Current Liabilities | 13.32M | 14.32M | 33.42M | 22.80M | 29.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 36.69M | 36.41M | 35.23M | 25.00M | 10.00M | |||
| Other Non-Current Liabilities | 25.17M | 25.64M | 25.88M | 24.50M | 17.40M | |||
| Total Non-Current Liabilities | 61.87M | 62.05M | 61.10M | 49.50M | 27.40M | |||
| TOTAL LIABILITIES | 75.18M | 76.37M | 94.52M | 72.30M | 56.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -473.60M | -462.50M | -419.57M | -367.40M | -302.00M | |||
| Additional Paid In Capital | 484.51M | 483.23M | 424.05M | 387.90M | 321.70M | |||
| Common Shares | 146.00K | 145.00K | 96.00K | 100.00K | 0.00 | |||
| Shares Outstanding | 146.44M | 145.49M | 96.24M | 77.60M | 30.80M | |||
| Tangible Book Value per Share | -0.06 | -0.00 | -0.19 | -0.05 | -0.22 | |||
| Total Shareholders' Equity | 11.06M | 20.88M | 4.58M | 20.60M | 19.70M | |||
| TOTAL LIABILITIES AND EQUITY | 86.24M | 97.24M | 99.10M | 92.90M | 76.10M | |||
| Statistics | ||||||||
| Debt/Equity | 3.32 | 1.74 | 7.69 | 1.21 | 0.51 | |||
| Current Ratio | 2.22 | 2.76 | 1.19 | 2.34 | 1.50 | |||
| Return On Assets (ROA) | -46.87% | -44.15% | -52.62% | -70.45% | -56.71% | |||
| Return On Equity (ROE) | -365.44% | -205.65% | -1138.56% | -317.72% | -219.09% | |||
All data in USD , ROIC based on taxRate of 0.21